Journal of General VirologyMicrobiologyPeer-reviewed journal article
The cellular Activating Protein 1 cFos regulates Influenza A virus replication
Antoine GerodeziD, François E. DufrasneiD, Olivier DenisiD, Mieke SteenselsiD, Bénédicte LambrechtiD, Lionel TafforeauiD, Caroline DemeretiD, Cyril BarbezangeiD
Abstract
Previous research has demonstrated that Influenza A virus (IAV) infection activates AP-1 transcription factors as part of the antiviral response. In this study, we identified cFos as the most upregulated AP-1 transcription factor during IAV infection in A549 human lung cells. Surprisingly, the knockdown of cFos resulted in impaired IAV replication. Fluorescence microscopy and functional analyses indicated that cFos is implicated in IAV infection through its nuclear function, rather than its cytoplasmic role as an activator of lipid synthesis. The investigation into the role of cFos in IAV infection revealed increased apoptosis and elevated interferon-{beta} mRNA levels in cFos-knockdown A549 cells during IAV infection. This suggests that cFos may enhance cell survival and reduce interferon-{beta} expression during infection, thereby facilitating IAV proliferation. Furthermore, the levels of viral NA mRNA and the expression of late viral proteins NA and M2 decreased upon cFos knockdown. Overall, this study identifies cFos as a proviral factor for IAV, through the modulation of innate immunity and apoptosis during infection, and potentially by supporting the viral transcription. Author SummaryInfluenza A viruses pose a significant threat to global public health. Understanding the interaction between the virus and host is essential for the development of antiviral therapies. We identified cFos, a cellular Activating Protein-1, as a pro-viral factor for influenza A viruses. cFos was found to enhance cell survival and regulate the expression of certain cytokines during viral infection. Our findings also suggested a potential role for cFos in the viral transcription, especially of the viral proteins expressed late in the viral cycle.
- organism: human
- assay: bulk RNA-seq
- research focus: host-pathogen & immune response
- approach: experimental assay
- Citations
- 3
- FWCI
- 13.88
- Field percentile
- top 2%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- c-Fos enhances influenza virus replication by stabilizing the M2 protein and promoting autophagosome accumulation
Xiaonan Chen, Junyang Yan, … Jiaojiao Peng·Journal of VirologyPeer-reviewed·Jul 27, 2026
- Maximal interferon induction by influenza lacking NS1 is infrequent owing to requirements for replication and export
A. C. Vicary, M. Mendes, … A. B. Russell·bioRxiv·Oct 24, 2022
- Fibroblast growth factor-9 expression in airway epithelial cells amplifies the type I interferon response and alters influenza A virus pathogenesis
B. Hiller, Y. Yin, … D. Lenschow·bioRxiv·Dec 22, 2021
- Kinetics Of Interferon-{lambda} And Receptor Expression In Response To In Vitro Respiratory Viral Infection
A. Lozhkov, N. Yolshin, … A. Vasin·bioRxiv·Dec 30, 2021
- Phosphorylation of JIP4 at S730 presents anti-viral properties against influenza A virus infection
J. Del Sarto, V. Gerlt, … S. Ludwig·bioRxiv·Jan 22, 2021
- Febrile temperature activates the innate immune response by promoting aberrant influenza A virus RNA synthesis
Karishma Bisht, Daniel Weilandt, … Aartjan J.W. te Velthuis·Science AdvancesPeer-reviewed·Jan 2, 2026